BSW
AMPE

Buckingham Strategic Wealth’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Buckingham Strategic Wealth’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed -$1K – 670
2022
Q3 		$1K Hold
33
– – ﹤0.01% 610
2022
Q2 		$2K Hold
33
– – ﹤0.01% 610
2022
Q1 		$5K Hold
33
– – ﹤0.01% 598
2021
Q4 		$6K Sell
33
-27
-45% -$10.1K ﹤0.01% 598
2021
Q3 		$30K Hold
60
– – ﹤0.01% 588
2021
Q2 		$30K Hold
60
– – ﹤0.01% 586
2021
Q1 		$30K Buy
60
+11
+22% +$5.67K ﹤0.01% 542
2020
Q4 		$24K Hold
49
– – ﹤0.01% 530
2020
Q3 		$14K Sell
49
-5
-9% -$1.24K ﹤0.01% 475
2020
Q2 		$10K Buy
+54
New +$8.98K ﹤0.01% 404

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Buckingham Strategic Wealth's AMPE Position: Q4 2022 in Review

Buckingham Strategic Wealth sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 33 shares — an estimated $1K sold.

Buckingham Strategic Wealth first reported a position in AMPE in Q2 2020 and held it in 10 quarters. The position peaked at $30K in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Buckingham Strategic Wealth reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Buckingham Strategic Wealth sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Buckingham Strategic Wealth first reported a position in Ampio Pharmaceuticals Inc. in Q2 2020 and held it in 10 quarters.
  • Buckingham Strategic Wealth's Ampio Pharmaceuticals Inc. position peaked at $30K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Buckingham Strategic Wealth's 13F filing for Q4 2022, filed 13 Feb 2023.